Abstract
Stereotactic body radiotherapy (SBRT) combines the challenge of meeting the stringent dosimetric requirements of stereotactic radiosurgery with that of accounting for the physiological movement of tumour and normal tissue. Here we present an overview of the history and development of SORT and discuss the radiobiological rationale upon which it is based. The published results of SORT for lung, liver, pancreas, kidney, prostate and spinal lesions are reviewed and summarised. The current evidence base is appraised and important ongoing trials are identified.
Original language | English |
---|---|
Pages (from-to) | 157-172 |
Number of pages | 16 |
Journal | Clinical Oncology |
Volume | 22 |
Issue number | 3 |
DOIs | |
Publication status | Published - Apr 2010 |
Keywords
- Cyberknife
- radiosurgery
- stereotactic body radiation therapy
- stereotactic body radiotherapy
- CELL LUNG-CANCER
- PRIMARY HEPATOCELLULAR-CARCINOMA
- ADVANCED PANCREATIC-CARCINOMA
- DOSE CONFORMAL RADIOTHERAPY
- SPINAL-CORD COMPRESSION
- RADIATION-THERAPY SBRT
- LOCAL TUMOR-CONTROL
- PHASE I/II TRIAL
- STAGE-I
- PROSTATE-CANCER